Pratima Kujur1 Chandrakala Joshi2
Sickle cell Anemia is an autosomal recessive genetic haematologic disorder. Although, Red cell transfusion is currently the most accepted therapy for most acute and many chronic complications of Sickle cell Anemia patients. To assess total number of transfusions, age at the start of transfusion, time interval between transfusions, indications and Transfusion Transmitted Infections (TTI). This is a prospective study in a blood bank in a tertiary care hospital in Raipur, over a period of 1 year. A total of 350 Sickle cell Anemia patients who were already diagnosed were included in study
